Abstract

Amiodarone accumulates in the liver, where it increases x-ray attenuation due to its iodine content. We evaluated liver attenuation in patients treated and not treated with amiodarone using true-non-contrast (TNC) and virtual-non-contrast (VNC) images acquired with spectral-detector-CT (SDCT). 142 patients, of which 21 have been treated with amiodarone, receiving SDCT-examinations (unenhanced-chest CT [TNC], CT-angiography of chest and abdomen [CTA-Chest, CTA-Abdomen]) were included. TNC, CTA-Chest, CTA-Abdomen, and corresponding VNC-images (VNC-Chest, VNC-Abdomen) were reconstructed. Liver-attenuation-index (LAI) was calculated as difference between liver- and spleen-attenuation. Liver-attenuation and LAI derived from TNC-images of patients receiving amiodarone were higher. Contrary to TNC, liver-attenuation and LAI were not higher in amiodarone patients in VNC-Chest and in VNC-Abdomen. To verify these initial results, a phantom scan was performed and an additional patient cohort included, both confirming that VNC is viable of accurately subtracting iodine of hepatic amiodarone-deposits. This might help to monitor liver-attenuation more accurately and thereby detect liver steatosis as a sign of liver damage earlier as well as to verify amiodarone accumulation in the liver.

Highlights

  • Amiodarone is an antiarrhythmic drug that has shown its effectiveness for several decades to treat various forms of tachyarrhythmia[1,2]

  • Five patients showed signs of severe liver steatosis indicated by a reduced liver attenuation (

  • This study quantitatively evaluated liver and spleen attenuation in patients with and without amiodarone treatment using TNC and virtual non-contrast images (VNC) from spectral-detector CT

Read more

Summary

Introduction

Amiodarone is an antiarrhythmic drug that has shown its effectiveness for several decades to treat various forms of tachyarrhythmia[1,2]. Atrial fibrillation yes n/a yes no no yes yes yes no yes n/a yes no n/a yes similarities to iodinated contrast media regarding the molecular structure It is a di-iodinated benzofuran derivate, as a drug it is usually orally delivered as amiodarone hydrochloride (C25H30ClI2NO3, molecular mass of 681.8 g/mol). Material decomposition can be used for the identification of iodine and thereby the creation of virtual non-contrast images (VNC) that offer a way to eliminate the iodine-associated attenuation from images This technique is used to remove iodine resulting from contrast media administration but it should be able to remove iodine bound to amiodarone[21,23,24,25]. Recently suggested[13], no study investigated the application of dual-energy CT for subtraction of the iodine in amiodarone patients

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call